106 related articles for article (PubMed ID: 9780789)
1. Clinical, histopathological, cytogenetic and prognostic differences between mucinous and nonmucinous colorectal adenocarcinomas.
Enríquez JM; Díez M; Tobaruela E; Lozano O; Domínguez P; González A; Mugüerza JM; Ratia T
Rev Esp Enferm Dig; 1998 Aug; 90(8):563-72. PubMed ID: 9780789
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
[TBL] [Abstract][Full Text] [Related]
3. [Clinico-pathological features and biological characterization of mucoid colorectal carcinoma].
Lanza G; Gafà R; Dubini A; Maestri I; Cavazzini L
Pathologica; 1995 Dec; 87(6):631-9. PubMed ID: 8927422
[TBL] [Abstract][Full Text] [Related]
4. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A
Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
6. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features of colorectal mucinous adenocarcinoma].
Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon.
Chen JS; Hsieh PS; Chiang JM; Yeh CY; Tsai WS; Tang R; Changchien CR; Wu RC
Chang Gung Med J; 2010; 33(1):51-7. PubMed ID: 20184795
[TBL] [Abstract][Full Text] [Related]
9. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics.
Song GA; Deng G; Bell I; Kakar S; Sleisenger MH; Kim YS
Int J Oncol; 2005 Mar; 26(3):745-50. PubMed ID: 15703832
[TBL] [Abstract][Full Text] [Related]
10. Colorectal carcinoma in different age groups: a population-based investigation.
Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
[TBL] [Abstract][Full Text] [Related]
11. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
[TBL] [Abstract][Full Text] [Related]
12. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
14. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
16. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
18. Mucinous colorectal carcinoma: clinical pathology and prognosis.
Okuno M; Ikehara T; Nagayama M; Kato Y; Yui S; Umeyama K
Am Surg; 1988 Nov; 54(11):681-5. PubMed ID: 2847606
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
[TBL] [Abstract][Full Text] [Related]
20. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]